Literature DB >> 2478887

Recognition of pre-processed endogenous antigen by class I but not class II MHC-restricted T cells.

M T Sweetser1, L A Morrison, V L Braciale, T J Braciale.   

Abstract

Class I and class II MHC-restricted T lymphocytes recognize non-native forms of antigen. The presentation of antigen to these two classes of T lymphocytes can occur through distinct pathways. Several mechanisms, including differences in antigen processing in different intracellular compartments, have been proposed to account for these pathway differences. Here we describe a T-cell epitope located on the influenza virus haemaglutinin, which is recognized by both class I and class II MHC-restricted cytolytic T lymphocytes (CTL). When expressed de novo in target cells, from a synthetic minigene encoding only the epitope, this pre-processed antigenic site is recognized by class I but not class II MHC-restricted T lymphocytes, even though target cells treated with the exogenously introduced peptide can be recognized by both classes of T cells. Because endogenous expression of the pre-processed antigenic fragment results in differential presentation to class I and class II MHC-restricted CTL, differences between the two different pathways of presentation could lie not at the level of processing but at the level of targeting and/or interaction of processed antigen with MHC.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478887     DOI: 10.1038/342180a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  36 in total

1.  Reassociation with beta 2-microglobulin is necessary for Kb class I major histocompatibility complex binding of exogenous peptides.

Authors:  K L Rock; L E Rothstein; S R Gamble; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules.

Authors:  P A Roche; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme.

Authors:  A Brooks; S Hartley; L Kjer-Nielsen; J Perera; C C Goodnow; A Basten; J McCluskey
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

4.  Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region.

Authors:  S Bahram; D Arnold; M Bresnahan; J L Strominger; T Spies
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

5.  Reassociation with beta 2-microglobulin is necessary for Db class I major histocompatibility complex binding of an exogenous influenza peptide.

Authors:  K L Rock; S Gamble; L Rothstein; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

6.  Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins.

Authors:  S Sanderson; K Frauwirth; N Shastri
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

Review 7.  MHC ligands and peptide motifs: first listing.

Authors:  H G Rammensee; T Friede; S Stevanoviíc
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

8.  Expression of intercellular adhesion molecule 1 (ICAM-1) during the development of invasion and/or metastasis of gastric carcinoma.

Authors:  S Koyama; T Ebihara; K Fukao
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

9.  Simian virus 40 T antigen as a carrier for the expression of cytotoxic T-lymphocyte recognition epitopes.

Authors:  T M Fu; R H Bonneau; M J Tevethia; S S Tevethia
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

10.  Identification of a dual-specific T cell epitope of the hemagglutinin antigen of an h5 avian influenza virus in chickens.

Authors:  Hamid R Haghighi; Leah R Read; S M Mansour Haeryfar; Shahriar Behboudi; Shayan Sharif
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.